reviewCancer Treatment ReviewsMar 26, 2020Closed access

Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook

JGJosep GarciaHIHerbert I. HurwitzABAlan B. SandlerDMDavid MilesRLRobert L. Coleman

Roche (Switzerland) · Mount Vernon Cancer Centre · +3 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,123
total citations
FWCI
48.06
Percentile
100%
References
127
Citations per year

Authors

7

Topics & keywords

Topics
Keywords
  • Bevacizumab
  • Medicine
  • Cancer
  • Oncology
  • Lung cancer
  • Targeted therapy
  • Clinical trial
  • Combination therapy
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding